| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 07/25/2001 | EP1117642A1 Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use |
| 07/25/2001 | CN1304930A Arylsulfurylisooximino acid derivative |
| 07/24/2001 | US6265559 Peptide nucleic acid synthons which have protecting groups which are orthogonal; allows removal of protecting groups under mild conditions; for pna-dna chimeras |
| 07/24/2001 | US6265410 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 07/24/2001 | US6265209 Subjecting racemic compound to transesterification with acylating agent in presence of hydrolase to optically resolve compound into optically active diester, then alcoholysis |
| 07/24/2001 | CA2218503C Arylsulfonyl hydroxamic acid derivatives |
| 07/19/2001 | WO2001051490A1 Methanocarba cycloalkyl nucleoside analogues |
| 07/19/2001 | WO2000041474A3 Anti-cd3 immunotoxins and therapeutic uses therefor |
| 07/19/2001 | US20010008946 Therapeutic nucleosides |
| 07/18/2001 | EP1115719A2 Novel amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
| 07/18/2001 | EP1115405A1 Use of certain drugs for treating nerve root injury |
| 07/18/2001 | CN1304402A Sulfonamide derivatives |
| 07/18/2001 | CN1068593C Process for preparing 2-alkoxyphenoxy sulfuric urea with heterocylic ring |
| 07/17/2001 | US6262295 Process for the preparation of a racemic or optically active 4-(hydroxymethyl)-2-cyclopentene derivative |
| 07/17/2001 | US6262254 8-fluoropurine compounds |
| 07/12/2001 | WO2001049688A1 Purine derivatives, process for their preparation and use thereof |
| 07/12/2001 | WO2001049687A2 Cyclohexene nucleic acids |
| 07/12/2001 | WO2001049275A2 Methods and compositions for mitigating pain using nitrate esters |
| 07/12/2001 | CA2396276A1 Purine derivatives, process for their preparation and use thereof |
| 07/12/2001 | CA2394184A1 Methods and compositions for mitigating pain using nitrate esters |
| 07/11/2001 | EP1113802A2 Antiviral combinations of lamivudine and adefovir |
| 07/10/2001 | US6258948 An n-acylamino compound; antiinflammatory agents, autoimmune diseases |
| 07/10/2001 | US6258809 6-aryloxy and arylthiopurines |
| 07/10/2001 | US6258794 Antidepressants and compounds that inhibit adenosine uptake |
| 07/05/2001 | WO2001047918A2 Azolyalkyl-oxa(di)azolyl pyri(mi)dine derivatives, a method for their production and their use as pesticides |
| 07/05/2001 | US20010006962 Behavior of biologically active compounds favorably modified by replacing a functional group with an unsaturated fatty derivative, e.g. elaidic acid; bioavailability; membrane passage; organ targeting; drugs; agriculture |
| 07/05/2001 | DE19962901A1 Azolylalkalylazol-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel Azolylalkalylazol-derivatives, processes for their preparation and their use as pesticides |
| 07/04/2001 | CN1301702A Internmediate of anti viral medicine, their preparation and use |
| 07/03/2001 | US6255485 Purine inhibitors of protein kinases, G proteins and polymerases |
| 07/03/2001 | US6255312 Acyclic nucleoside derivatives |
| 07/03/2001 | US6254889 Solid dispersion dosage form of amorphous xanthine derivative and enteric-coating polymer |
| 07/03/2001 | CA2120677C Xanthine derivatives |
| 06/28/2001 | WO2001046200A1 Novel piperidine and piperazine derivatives |
| 06/28/2001 | WO2001045686A2 Formulations of adenosine a1 agonists |
| 06/28/2001 | WO2001045684A2 Formulations of adenosine a1 agonists |
| 06/28/2001 | WO2000075142A3 Dna methyltransferase inhibitors |
| 06/28/2001 | WO1999063937A9 Multivalent macrolide antibiotics |
| 06/28/2001 | CA2394095A1 Novel piperidine and piperazine derivatives |
| 06/27/2001 | EP1109544A1 Potassium channel inhibitors and method |
| 06/27/2001 | EP1109543A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
| 06/26/2001 | US6252112 Process for the preparation of an enantiomer of a (1R, 4S) or (1S, 4R)-1-amino-4-(hydroxymethyl)-2-cyclopentene derivative |
| 06/26/2001 | US6252075 Reacting a 7-benzylpurine compound with a 1,3-dioxepane compound |
| 06/26/2001 | US6252061 Process for the production of 2-halo-6-aminopurine derivatives |
| 06/21/2001 | WO2001044265A1 Treatment of mental conditions including depression |
| 06/21/2001 | WO2001044248A1 Imidazopyrimidinyl and imidazopyridinyl derivatives |
| 06/21/2001 | WO2001043845A1 Method and device for capturing fine particles by trapping in a solid mixture of carbon dioxide snow type |
| 06/21/2001 | US20010004668 By reaction of 2-amino-6-chloropurine with 2-acetoxymethyl-4-(leaving group)-but-1-yl acetate to give 9-(4-acetoxy-3-acetoxymethylbut-1-yl)-2-amino- 6-chloropurine, thereafter hydrolysing or reducing |
| 06/21/2001 | CA2392992A1 Imidazopyrimidinyl and imidazopyridinyl derivatives |
| 06/20/2001 | EP1107758A2 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase |
| 06/19/2001 | USRE37234 Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses |
| 06/19/2001 | US6248746 Phosphodiesterase (pde-iv) inhibitor for treatment of asthma, allergies, atopic diseases and rhinitis |
| 06/13/2001 | EP1105730A1 Enzyme inhibition immunoassay |
| 06/13/2001 | EP0805812B1 Bicyclic substituted hexahydrobenz(e)isoindole alpha-1- adrenergic antagonists |
| 06/13/2001 | CN1067073C Acyclic nucleoside derivatives |
| 06/12/2001 | US6245910 Process for producing purine derivatives |
| 06/12/2001 | CA2046002C Purinyl and pyrimidinyl tetrahydrofurans |
| 06/07/2001 | WO1999063940A3 INHIBITORS OF H+K+-ATPase |
| 06/07/2001 | DE19952146A1 Arylalkane, Arylalkene und Aryl-azaalkane, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Arylalkanes, aryl alkenes and aryl azaalkane, pharmaceutical compositions containing them and methods for their preparation |
| 06/06/2001 | EP1104422A1 Phenyl xanthine derivatives |
| 06/06/2001 | EP1104415A1 Method of manufacture of 1,3-oxathiolane nucleosides |
| 06/06/2001 | EP0802914B1 Aryl- and heteroaryl- purine and pyridopyrimidine derivatives |
| 06/05/2001 | US6243102 Data-driven layout engine |
| 06/05/2001 | US6242599 Reacting 2,4-diamino-5-formylamino-6-hydroxypyrimidine with formic acid, in the absence of formamide |
| 06/05/2001 | US6242470 Rheumatic diseases; antiarthritic agents, antiallergens; irritable bowel syndrome; amidation |
| 06/05/2001 | US6242429 Antiviral ara-a derivatives having resistance to metabolism by adenosinedeaminase |
| 05/31/2001 | WO2000073307A3 Substituted 8-phenylxanthines useful as antagonists of a2b adenosine receptors |
| 05/30/2001 | EP1102782A1 Structural analogs of amine bases and nucleosides |
| 05/30/2001 | EP1102768A1 Substituted pyrazole derivatives condensed with six-membered heterocyclic rings |
| 05/30/2001 | EP0656778B1 Enantiomerically pure beta-d-dioxolane-nucleosides |
| 05/30/2001 | CN1066448C Amide derivs. |
| 05/29/2001 | US6238855 Photographic element containing a DIR coupler |
| 05/29/2001 | CA2053339C Hydroxymethyl(methylenecyclopentyl) purines and pyrimidines |
| 05/25/2001 | WO2001036419A1 Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue |
| 05/25/2001 | WO2001036416A1 Novel thiazolidinedione derivatives as antidiabetic agents |
| 05/25/2001 | CA2391913A1 Novel thiazolidinedione derivatives as antidiabetic agents |
| 05/25/2001 | CA2387809A1 Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue |
| 05/23/2001 | CN1066147C Purine derivatives and processes for their preparation |
| 05/23/2001 | CN1066146C Use of theophylline derivatives for curing and preventing shock state, xanthine derivatives and preparation thereof |
| 05/22/2001 | CA2013380C Selective adenosine receptor agents |
| 05/17/2001 | WO2001034610A1 Polycycloalkylpurines as adenosine receptor antagonists |
| 05/17/2001 | WO2001034604A2 Adenosine receptor antagonists and methods of making and using the same |
| 05/17/2001 | WO2001034573A1 Compounds |
| 05/17/2001 | WO2001014358A3 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans |
| 05/17/2001 | CA2390496A1 Polycycloalkylpurines as adenosine receptor antagonists |
| 05/16/2001 | EP1098870A2 Nitric esters and nitrate salts of specific drugs |
| 05/16/2001 | EP1098657A1 Composition for treating obesity and aesthetic treatment method |
| 05/16/2001 | EP0756597B1 Preparation of purines |
| 05/15/2001 | US6232321 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 05/10/2001 | WO2001032649A1 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof |
| 05/10/2001 | WO2001032615A1 1,4 substituted piperidinyl nmda/nr2b antagonists |
| 05/10/2001 | WO2001032182A1 Us0027324for eating disorders |
| 05/10/2001 | CA2389226A1 1,4 substituted piperidinyl nmda/nr2b antagonists |
| 05/10/2001 | CA2387613A1 Arylalkanes, arylalkenes and aryl-azaalkanes, pharmaceutical compositions containing these compounds and processes for preparing them |
| 05/09/2001 | EP1097719A1 NEP inhibitors for the treatment of female sexual dysfunction |
| 05/09/2001 | EP1097718A1 NPY antagonists for the treatment of female sexual dysfunction |
| 05/09/2001 | EP1097711A2 Treatment of pulmonary hypertension |
| 05/09/2001 | EP1097707A1 Treatment of female sexual dysfunction |
| 05/09/2001 | EP1097706A1 Phosphodiesterase inhibitors for the treatment of female sexual dysfunction |
| 05/09/2001 | CN1294591A Process for prodn. of purine derivatives |
| 05/09/2001 | CN1294590A Method of 3-substituted adenines via 2-thioxanthines |